{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:32:07Z","timestamp":1790796727795,"version":"4.1.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Technology use, including continuous glucose monitoring (CGM) and insulin pump therapy, is associated with improved outcomes in youth with type 1 diabetes (T1D). In 2017 CGM was universally funded for youth with T1D in Australia. In contrast, pump access is primarily accessed through private health insurance, self-funding or philanthropy. The study aim was to investigate the use of diabetes technology across different socioeconomic groups in Australian youth with T1D, in the setting of two contrasting funding models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional evaluation of 4957 youth with T1D aged &amp;lt;18 years in the national registry was performed to determine technology use. The Index of Relative Socio-Economic Disadvantage (IRSD) derived from Australian census data is an area-based measure of socioeconomic status (SES). Lower quintiles represent greater disadvantage. IRSD based on most recent postcode of residence was used as a marker of SES. A multivariable generalised linear model adjusting for age, diabetes duration, sex, remoteness classification, and location within Australia was used to determine the association between SES and device use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CGM use was lower in IRSD quintile 1 in comparison to quintiles 2 to 5 (p&amp;lt;0.001) where uptake across the quintiles was similar. A higher percentage of pump use was observed in the least disadvantaged IRSD quintiles. Compared to the most disadvantaged quintile 1, pump use progressively increased by 16% (95% CI: 4% to 31%) in quintile 2, 19% (6% to 33%) in quintile 3, 35% (21% to 50%) in quintile 4 and 51% (36% to 67%) in the least disadvantaged quintile 5.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this large national dataset, use of diabetes technologies was found to differ across socioeconomic groups. For nationally subsidised CGM, use was similar across socioeconomic groups with the exception of the most disadvantaged quintile, an important finding requiring further investigation into barriers to CGM use within a nationally subsidised model. User pays funding models for pump therapy result in lower use with socioeconomic disadvantage, highlighting inequities in this funding approach. For the full benefits of diabetes technology to be realised, equitable access to pump therapy needs to be a health policy priority.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2023.1178958","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T13:04:27Z","timestamp":1692623067000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Socioeconomic status and diabetes technology use in youth with type 1 diabetes: a comparison of two funding models"],"prefix":"10.3389","volume":"14","author":[{"given":"Kate E.","family":"Lomax","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig E.","family":"Taplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary B.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aveni","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Zomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina L.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Clapin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Zoungas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia J.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin I.","family":"de Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy W.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6940","article-title":"Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: A randomized clinical trial","volume":"323","author":"Laffel","year":"2020","journal-title":"Jama"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1674","article-title":"Glycemic outcome associated with insulin pump and glucose sensor use in children and adolescents with type 1 diabetes. Data from the international pediatric registry SWEET","volume":"44","author":"Cardona-Hernandez","year":"2021","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1358","article-title":"Reduction in diabetic ketoacidosis and severe hypoglycemia in pediatric type 1 diabetes during the first year of continuous glucose monitoring: A multicenter analysis of 3,553 subjects from the DPV registry","volume":"43","author":"Tauschmann","year":"2020","journal-title":"Diabetes Care"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-0304","article-title":"Continuous glucose monitoring improves glycemic outcomes in children with type 1 diabetes: real-world data from a population-based clinic","volume":"44","author":"Sanderson","year":"2021","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00125-015-3790-6","article-title":"Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries","volume":"59","author":"Sherr","year":"2016","journal-title":"Diabetologia"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153033","article-title":"Insulin pump therapy is associated with lower rates of retinopathy and peripheral nerve abnorMality","volume":"11","author":"Zabeen","year":"2016","journal-title":"PloS One"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h3234","article-title":"Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study","volume":"350","author":"Steineck","year":"2015","journal-title":"BMJ: Br Med J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.ajo.2015.07.024","article-title":"Interventions for diabetic retinopathy in type 1 diabetes: systematic review and meta-analysis","volume":"160","author":"Virk","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-3007-9","article-title":"Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case\u2013control study","volume":"56","author":"Johnson","year":"2013","journal-title":"Diabetologia"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12754","article-title":"Real-world outcomes of insulin pump compared to injection therapy in a population-based sample of children with type 1 diabetes","volume":"19","author":"Burckhardt","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13421","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery","volume":"23","author":"Sherr","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-S007","article-title":"7. Diabetes technology: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2022","journal-title":"Diabetes Care"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2017.0096","article-title":"Continuous glucose monitoring and global reimbursement: an update","volume":"19","author":"Graham","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0303","article-title":"Current eligibility requirements for CGM coverage are harmful, costly, and unjustified","volume":"22","author":"Anderson","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12833","article-title":"Persistent heterogeneity in diabetes technology reimbursement for children with type 1 diabetes: The SWEET perspective","volume":"20","author":"Sumnik","year":"2019","journal-title":"Pediatr Diabetes"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12847","article-title":"The association between socio-economic status and diabetes care and outcome in children with diabetes type 1 in Germany: The DIAS study (diabetes and social disparities)","volume":"20","author":"M\u00f6nkem\u00f6ller","year":"2019","journal-title":"Pediatr Diabetes"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13079","article-title":"Young people with Type 1 diabetes of non-white ethnicity and lower socio-economic status have poorer glycaemic control in England and Wales","volume":"33","author":"Khanolkar","year":"2016","journal-title":"Diabetes Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0257","article-title":"A decade of disparities in diabetes technology use and hbA(1c) in pediatric type 1 diabetes: A transatlantic comparison","volume":"44","author":"Addala","year":"2021","journal-title":"Diabetes Care"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2012.12.010","article-title":"Social determinants of health on glycemic control in pediatric type 1 diabetes","volume":"162","author":"Zuijdwijk","year":"2013","journal-title":"J Pediatr"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2019.0393","article-title":"HbA1c levels in type 1 diabetes from early childhood to older adults: A deeper dive into the influence of technology and socioeconomic status on hbA1c in the T1D exchange clinic registry findings","volume":"22","author":"Miller","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2022.0388","article-title":"Mediating effects of technology-based therapy on the relationship between socioeconomic status and glycemic management in pediatric type 1 diabetes","volume":"25","author":"Stanley","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"B22","unstructured":"The Australian health system2019"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-1666","article-title":"Universal subsidized continuous glucose monitoring funding for young people with type 1 diabetes: uptake and outcomes over 2 years, a population-based study","volume":"45","author":"Johnson","year":"2022","journal-title":"Diabetes Care"},{"key":"B24","unstructured":"Insulin pump program2021"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14714","article-title":"Comparison of MiniMed 780G system performance in users aged younger and older than 15\u2009years: Evidence from 12\u2009870 real-world users","volume":"24","author":"Arrieta","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1099024","article-title":"One-year follow-up comparison of two hybrid closed-loop systems in Italian children and adults with type 1 diabetes","volume":"14","author":"Bassi","year":"2023","journal-title":"Front Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/dme.15015","article-title":"Real world use of hybrid-closed loop in children and young people with type 1 diabetes mellitus\u2014a National Health Service pilot initiative in England","volume":"40","author":"Ng","year":"2023","journal-title":"Diabetic Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1177\/1932296816648983","article-title":"Australasian diabetes data network: building a collaborative resource","volume":"10","author":"Clapin","year":"2016","journal-title":"J Diabetes Sci technol"},{"key":"B29","unstructured":"Diabetes data snapshots - Type 1 diabetes as at 31 December 20222022"},{"key":"B30","unstructured":"2021"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/1753-6405.12970","article-title":"The case for action on socioeconomic differences in overweight and obesity among Australian adults: modelling the disease burden and healthcare costs","volume":"44","author":"Gearon","year":"2020","journal-title":"Aust N Z J Public Health"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2018-316303","article-title":"Adherence to metformin is reduced during school holidays and weekends in children with type 1 diabetes participating in a randomised controlled trial","volume":"104","author":"Leggett","year":"2019","journal-title":"Arch Dis Child"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13327","article-title":"Moderate and severe diabetic ketoacidosis at type 1 diabetes onset in children over two decades: A population-based study of prevalence and long-term glycemic outcomes","volume":"23","author":"Clapin","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"B34","unstructured":"Australian Statistical Geography Standard (ASGS): Volume 5 - Remoteness Structure2016"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.5694\/mja16.00737","article-title":"The Australasian Diabetes Data Network: first national audit of children and adolescents with type 1 diabetes","volume":"206","author":"Phelan","year":"2017","journal-title":"Med J Aust"},{"key":"B36","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1399-543X.2006.00153.x","article-title":"Independent effects of socioeconomic status and place of residence on the incidence of childhood type 1 diabetes in Western Australia","volume":"7","author":"Haynes","year":"2006","journal-title":"Pediatr Diabetes"},{"key":"B37","doi-asserted-by":"publisher","first-page":"100644","DOI":"10.1016\/j.lanwpc.2022.100644","article-title":"Inequity in access to continuous glucose monitoring and health outcomes in paediatric diabetes, a case for national continuous glucose monitoring funding: A cross-sectional population study of children with type 1 diabetes in New Zealand","volume":"31","author":"Burnside","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2013.0132","article-title":"Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes","volume":"15","author":"Lin","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"B39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jpeds.2009.01.063","article-title":"Predictors of insulin regimens and impact on outcomes in youth with type 1 diabetes: the SEARCH for Diabetes in Youth study","volume":"155","author":"Paris","year":"2009","journal-title":"J Pediatr"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2337\/dci20-0048","article-title":"Racial and socioeconomic disparities in pediatric type 1 diabetes: time for a paradigm shift in approach","volume":"44","author":"Lipman Terri","year":"2021","journal-title":"Diabetes Care"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-1774","article-title":"Racial-ethnic disparities in management and outcomes among children with type 1 diabetes","volume":"135","author":"Willi","year":"2015","journal-title":"Pediatrics"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1177\/19322968211006476","article-title":"Provider implicit bias impacts pediatric type 1 diabetes technology recommendations in the United States: findings from the gatekeeper study","volume":"15","author":"Addala","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13213","article-title":"Self-reported insulin pump prescribing practices in pediatric type 1 diabetes","volume":"22","author":"Fredette","year":"2021","journal-title":"Pediatr diabetes"},{"key":"B44","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jcjd.2021.02.005","article-title":"Social determinants of health, goals and outcomes in high-risk children with type 1 diabetes","volume":"45","author":"Hershey","year":"2021","journal-title":"Can J Diabetes"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2337\/dci20-0053","article-title":"Social determinants of health and diabetes: A scientific review","volume":"44","author":"Hill-Briggs","year":"2020","journal-title":"Diabetes Care"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1178958\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T13:04:31Z","timestamp":1692623071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1178958\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":45,"alternative-id":["10.3389\/fendo.2023.1178958"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1178958","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]},"article-number":"1178958"}}